273
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Talimogene laherparepvec in the treatment of melanoma

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guy R Simpson, Kate Relph, Kevin Harrington, Alan Melcher & Hardev Pandha. (2016) Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic Virotherapy 5, pages 1-13.
Read now

Articles from other publishers (6)

Luo-Qin Fu, Shi-Bing Wang, Mao-Hua Cai, Xue-Jun Wang, Jin-Yang Chen, Xiang-Min Tong, Xiao-Yi Chen & Xiao-Zhou Mou. (2019) Recent advances in oncolytic virus-based cancer therapy. Virus Research 270, pages 197675.
Crossref
J. Ressler, R. Silmbrod, A. Stepan, F. Tuchmann, A. Cicha, K. Uyanik‐Ünal & C. Hoeller. (2019) Talimogene laherparepvec (T‐ VEC ) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report . British Journal of Dermatology 181:1, pages 186-189.
Crossref
C. Zamora, M. Lopez, F. Cunningham, F. Collichio & M. Castillo. (2017) Imaging Manifestations of Pseudoprogression in Metastatic Melanoma Nodes Injected with Talimogene Laherparepvec: Initial Experience. American Journal of Neuroradiology 38:6, pages 1218-1222.
Crossref
Dezső P. Virók, Ildikó Eszik, Tímea Mosolygó, Kamil Önder, Valéria Endrész & Katalin Burián. (2017) A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies. Journal of Virological Methods 242, pages 46-52.
Crossref
Tiantian Zhang, Yogesh R. Suryawanshi, Dennis H. Kordish, Helene M. Woyczesczyk, David Jeng & Karim Essani. (2016) Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice. Virus Genes 53:1, pages 52-62.
Crossref
Antonia Digklia & Olivier Michielin. (2016) The cutting edge of metastatic melanoma therapy. Melanoma Management 3:3, pages 217-229.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.